Home Search
gene therapy - search results
If you're not happy with the results, please do another search
Drug development for Alzheimer’s disease
Ramón Cacabelos, of EuroEspes Biomedical Research Center discusses the strides being made in drug development for Alzheimer's disease...
Alzheimer’s disease (AD) is a major problem of health and a national priority in developed countries. Despite enormous efforts by governments, the scientific community and the pharmaceutical industry over the past 50 years,...
A European leader in cancer clinical trials
Denis Lacombe, John Bean and Mathilde Fenoulhet from the European Organisation for Research and Treatment of Cancer (EORTC) outline how clinical trials play an integral role in tackling cancer…Â
The European Organisation for Research and Treatment of Cancer (EORTC) is a European, academic, cancer clinical research organisation. A leader in...
Nuclear Medicine in Dusseldorf
The Clinic of Nuclear Medicine at the University Hospital is located both in DĂĽsseldorf and at the Research Center JĂĽlich, and runs a nuclear medical out-patient department covering the whole spectrum of radioisotope scanning from thyroid and skeleton scintigraphy to examinations of amino acid metabolism for tumor diagnosis. As...
Research at Oslo University Hospital in the field of Gynaecologic cancer
Oslo University Hospital (OUS) is a big hospital formed by the merger of 4 hospitals. The State Hospital, the Norwegian Radium Hospital, Ullevaal Hospital and Aker Hospital. It serves as a local hospital for about 600,000 inhabitants and as a referral centre for about 2.8 million people. As a...
Reducing the burden of cancer
AG highlights the work of the National Cancer Institute (NCI), to reduce and treat cancer.
The National Cancer Institute (NCI) is the U.S. Federal government’s primary agency for cancer research and training. As part of the National Institutes of Health (NIH) they coordinate with the National Cancer Programme, which conducts...
Drug development for Alzheimer’s disease
Alzheimer's disease (AD) is a major problem of health and a national priority in developed countries. Despite enormous efforts by governments, the scientific community and the pharmaceutical industry over the past 50 years, no therapeutic breakthroughs have yet been achieved, and the drugs available for the treatment of AD...
Are we standing in our own way on the path to a cure for...
Although there are many reasons to celebrate the life-extending benefits from antiretroviral therapeutics (ART) for HIV/AIDS and the ability to chronically manage patients’ disease for decades, the majority of people around the world living with the virus do not have access to ART and those that do, have over...
Tackling cancer in children and adolescents
Professor Giles Vassal, President of the European Society for Paediatric Oncology outlines why it is crucial for Europe to come together and tackle and prevent cancer in children.
Compared to the incidence in adults, cancer is rare in children and adolescents but concerns 35,000 young people each year in Europe. Despite...
Prediction of cancer treatment outcome using physics
Vittorio Cristini1,2, Eugene J. Koay3, and Zhihui Wang1,2
1Department of NanoMedicine and Biomedical Engineering, University of Texas Medical School at Houston, Houston, TX 77054, USA
2Brown Foundation Institute of Molecular Medicine, University of Texas Medical School at Houston, Houston, TX 77030, USA
3Department of Radiation Oncology, University of Texas MD Anderson Cancer...
Depression in adolescence
Dr Rhys Bevan Jones, Clinical Research Fellow at the Institute of Psychological Medicine & Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics at Cardiff University details how depression can affect adolescents…
Depression is common in young people, with around 1 in 20 of those in adolescence affected. This leads...
Million dollar question in prostate cancer research
Owen Sharp, CEO at Prostate Cancer UK sheds light on the important work that’s being done to better diagnose and treat prostate cancer…
Most prostate cancers aren’t a problem. In fact, for many the problems only come from diagnosing and treating them. These are the prostate cancers a surgeon once...
Towards miniature electron accelerators for a wide range of applications
Particle accelerators have already become useful, and in many cases an indispensable tool in many applications, such as medical treatments (radiotherapy, production of isotopes for PET), industry (material irradiation and sterilisation, industrial radiography) and safety control (cargo inspection).
More than 90% of accelerators in operation nowadays are machines, producing beams...
Understanding coronary artery disease in postmenopausal ladies
Dr Stefano Savonitto, Director of Cardiology at Manzoni Hospital sheds light on the risk of heart disease in womenÂ
When thinking about their health, women are especially concerned about cancer. However, the most frequent cause of death among women is heart disease and especially coronary artery disease. The number of...
The million dollar question in prostate cancer research
Owen Sharp, CEO at Prostate Cancer UK sheds light on the important work that’s being done to better diagnose and treat prostate cancer
Most prostate cancers aren’t a problem. In fact, for many, the problems only come from diagnosing and treating them. These are the prostate cancers a surgeon once...
Liver cancer: Future scientific and clinical challenges and forthcoming problems in Europe
Hepatocellular carcinoma (HCC) reflects the most common primary liver cancer as well as the 2nd most common cause of cancer related death in humans worldwide. In most cases HCC is caused by chronic liver damage that is either induced by chronic viral infections (e.g. Hepatitis B or C viruses),...
The importance of effective wound care
Alexandra Bishop, Tissue Viability Nurse Specialist at Plymouth Wound Care discusses how effective wound care can make all the difference to a patient, and the NHS…
The importance of effective wound care cannot be underestimated. Wounds in complex patients and those that are poorly managed can lead to the development of...
Skin cancer: deadly but preventable
Jon Pleat MA DPhil FRCS(Plast), Plastic Surgeon and Scientific Advisor at SCaRF details the risks of skin cancer and how it can be prevented…
Skin cancer is the most common form of cancer globally. There are more than 80,000 deaths a year from its different forms. Within the UK, the incidence...
The importance of effective wound care
Alexandra Bishop, Tissue Viability Nurse Specialist at Plymouth Wound Care discusses how effective wound care can make all the difference to a patient, and the NHS
The importance of effective wound care cannot be underestimated. Wounds in complex patients and those that are poorly managed can lead to the development of...
Skin cancer: deadly but preventable
Jon Pleat MA DPhil FRCS(Plast), Plastic Surgeon and Scientific Advisor at SCaRF details the risks of skin cancer and how it can be prevented
Skin cancer is the most common form of cancer globally. There are more than 80,000 deaths a year from its different forms. Within the UK, the incidence...
Predicting drug responses
Luminex xTAG® CYP2D6 Kit v3 and xTAG® CYP2C19 Kit v3 assays may aid in determining therapeutic strategies for drugs metabolized by CYP2D6 and CYP2C19 gene products
Physicians have long been aware of the subtle differences between patients and their responses to medications. The recognition that a part of this variation...